Skip to main content
. 2019 Jul-Sep;15(3):311–316. doi: 10.4183/aeb.2019.311

Table 7.

Oral antidiabetic agents usage rate in two groups

OAD HbA1c < 7% HbA1c ≥ 7% P Hypoglycemia (-) Hypoglycemia (+) p
Metformin 78.1% 77.4% 0.863 78.3% 76.7% 0.651
Sulphonylurea 20.9% 16.2% 0.153 16.6% 17.0% 0.892
Glinide 1.0% 5.2% 0.013 2.3% 6.3% 0.009
Pioglitazone 1.0% 0.5% 0.370 0.7% 0.6% 0.664
Acarbose 4.7% 3.8% 0,602 4.0% 6.8% 0.124
Glp1a 0.5% 1.2% 0.392 1.2% 0% 0.140
Dpp4i 24.6% 38.6% 0.001 35.3% 29.0% 0.120
Sglt2i 1.0% 4.0% 0.048 2.4% 3.4% 0.489